Search Results - "Erim, Daniel O"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1

    Prevalence and predictors of probable depression in prostate cancer survivors by Erim, Daniel O., Bensen, Jeannette T., Mohler, James L., Fontham, Elizabeth T. H., Song, Lixin, Farnan, Laura, Delacroix, Scott E., Peters, Edward S., Erim, Theodora N., Chen, Ronald C., Gaynes, Bradley N.

    Published in Cancer (01-10-2019)
    “…Background The early diagnosis and treatment of depression are cancer care priorities. These priorities are critical for prostate cancer survivors because men…”
    Get full text
    Journal Article
  2. 2

    Associations between prostate cancer‐related anxiety and health‐related quality of life by Erim, Daniel O., Bennett, Antonia V., Gaynes, Bradley N., Basak, Ram S., Usinger, Deborah, Chen, Ronald C.

    Published in Cancer medicine (Malden, MA) (01-06-2020)
    “…Background There are uncertainties about prostate cancer‐related anxiety's (PCRA) associations with health‐related quality of life (HRQOL) and major…”
    Get full text
    Journal Article
  3. 3

    A rapid assessment of the availability and use of obstetric care in Nigerian healthcare facilities by Erim, Daniel O, Kolapo, Usman M, Resch, Stephen C

    Published in PloS one (22-06-2012)
    “…As part of efforts to reduce maternal deaths in Nigeria, pregnant women are being encouraged to give birth in healthcare facilities. However, little is known…”
    Get full text
    Journal Article
  4. 4

    The spillover effect of midwife attrition from the Nigerian midwives service scheme by Erim, Daniel O, Offiong, Harrison E, Kim, Christine, Bello, Folasade A, Moulton, Jeremy, Wheeler, Stephanie B, Thirumurthy, Harsha

    Published in BMC health services research (23-04-2018)
    “…The Nigerian Midwives Service Scheme (MSS) increased use of antenatal services at rural public sector clinics. However, it is unclear if women who would not…”
    Get full text
    Journal Article
  5. 5

    Assessing health and economic outcomes of interventions to reduce pregnancy-related mortality in Nigeria by Erim, Daniel O, Resch, Stephen C, Goldie, Sue J

    Published in BMC public health (14-09-2012)
    “…Women in Nigeria face some of the highest maternal mortality risks in the world. We explore the benefits and cost-effectiveness of individual and integrated…”
    Get full text
    Journal Article
  6. 6

    Cost-Effectiveness of Providing the Depression Care for People With Cancer Program to Patients With Prostate Cancer in the United States by Erim, Daniel O.

    Published in Value in health (01-02-2021)
    “…The Depression Care for People with Cancer program (DCPC) is a cost-effective depression care model for UK patients with cancer. However, DCPC’s…”
    Get full text
    Journal Article
  7. 7

    Patterns and predictors of self‐reported clinical diagnosis and treatment for depression in prostate cancer survivors by Erim, Daniel O., Bensen, Jeannette T., Mohler, James L., Fontham, Elizabeth T. H., Song, Lixin, Farnan, Laura, Delacroix, Scott E., Peters, Edward S., Erim, Theodora N., Chen, Ronald C., Gaynes, Bradley N.

    Published in Cancer medicine (Malden, MA) (01-07-2019)
    “…Background Appropriate depression care is a cancer‐care priority. However, many cancer survivors live with undiagnosed and untreated depression. Prostate…”
    Get full text
    Journal Article
  8. 8

    Mapping the Memorial Anxiety Scale for Prostate Cancer to the SF-6D by Erim, Daniel O., Bennett, Antonia V., Gaynes, Bradley N., Basak, Ram Sankar, Usinger, Deborah, Chen, Ronald C.

    Published in Quality of life research (01-10-2021)
    “…Purpose To create a crosswalk that predicts Short Form 6D (SF-6D) utilities from Memorial Anxiety Scale for Prostate Cancer (MAX-PC) scores. Methods The data…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Cost-effectiveness of Prophylaxis Against Pneumocystis jiroveci Pneumonia in Patients with Crohn's Disease by Okafor, Philip N, Farraye, Francis A, Okafor, Adetoro T, Erim, Daniel O

    Published in Digestive diseases and sciences (01-12-2015)
    “…Emerging evidence suggests that Pneumocystis jiroveci pneumonia is occurring more frequently in Crohn's disease patients on immunosuppressive medications,…”
    Get full text
    Journal Article
  12. 12

    Cost-effectiveness of Prophylaxis Against Pneumocystisjiroveci Pneumonia in Patients with Crohn’s Disease by Okafor, Philip N., Farraye, Francis A., Okafor, Adetoro T., Erim, Daniel O.

    Published in Digestive diseases and sciences (01-12-2015)
    “…Background Emerging evidence suggests that Pneumocystis jiroveci pneumonia is occurring more frequently in Crohn’s disease patients on immunosuppressive…”
    Get full text
    Journal Article
  13. 13

    Associations of Government-Mandated Closures and Restrictions With Aggregate Mobility Trends and SARS-CoV-2 Infections in Nigeria by Erim, Daniel O, Oke, Gbemisola A, Adisa, Akinyele O, Odukoya, Oluwakemi, Ayo-Yusuf, Olalekan A, Erim, Theodora Nawa, Tsafa, Tina N, Meremikwu, Martin M, Agaku, Israel T

    Published in JAMA network open (04-01-2021)
    “…To prepare for future coronavirus disease 2019 (COVID-19) waves, Nigerian policy makers need insights into community spread of COVID-19 and changes in rates of…”
    Get full text
    Journal Article
  14. 14

    The Value of Vedolizumab as Rescue Therapy in Moderate-Severe Crohn’s Disease Patients with Adalimumab Non-response in the USA by Erim, Daniel O., Mahendraratnam, Nirosha, Okafor, Phillip N., Wheeler, Stephanie B.

    Published in Journal of Crohn's and colitis (01-08-2015)
    “…Background and aims: In May 2014, vedolizumab was approved by the Food and Drug Administration for the treatment of moderate-to-severe Crohn’s disease. In…”
    Get full text
    Journal Article
  15. 15

    Cost-effectiveness of nonmelanoma skin cancer screening in Crohn's disease patients by Okafor, Philip N, Stallwood, Christopher G, Nguyen, Linda, Sahni, Debjani, Wasan, Sharmeel K, Farraye, Francis A, Erim, Daniel O

    Published in Inflammatory bowel diseases (01-12-2013)
    “…Several studies have demonstrated an increased risk of nonmelanoma skin cancer (NMSC) in patients with inflammatory bowel disease, with the greatest risk in…”
    Get full text
    Journal Article
  16. 16
  17. 17